Neurologic clinical trial - PVT-2201-301

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05349721

 PVT-2201-301

Drug

Brepocitinib

Phase

Phase III

Condition

Dermatomyositis

Keywords

Amyotrophic Lateral Sclerosis